Cancerous Inhibitor Of PP2A (CIP2A) Polyclonal Antibody
Selected Variant
CAU21077-01
Size: 100 µL
The Cancerous Inhibitor Of PP2A (CIP2A) Polyclonal Antibody is applicable for the following applications: WB, IHC, ICC, IP. Host: Rabbit. Species Reactivity: Human (Homo sapiens), Mouse (Mus musculus) . Immunogen: Recombinant CIP2A expressed in E. coli. Accession Number: Q8TCG1. Gene ID: 57650. Target Synonyms: p90; KIAA1524. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Product Specifications
CAS Number
9007-83-4
Short Description
The Cancerous Inhibitor Of PP2A (CIP2A) Polyclonal Antibody is applicable for the following applications: WB, IHC, ICC, IP.
Gene ID
57650
Accession Number
Q8TCG1
Host
Rabbit
Reactivity
Human (Homo sapiens), Mouse (Mus musculus)
Immunogen
Recombinant CIP2A expressed in E. coli
Target
Cancerous Inhibitor Of PP2A (CIP2A)
Clonality
Polyclonal
Conjugation
Applications
WB, IHC, ICC, IP
Field of Research
Tumor Immunity
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Concentration
0.28mg/ml
Buffer
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol
Shipping Conditions
Ice packs
Storage Conditions
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Appearance
Liquid
Target Alternative Name
P90; KIAA1524
Species
Human (Homo sapiens)
IHC description
IHC Validated
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MMP3 (Marker of Metastasis and Rheumatoid Arthritis) (MMP3/1994R), 0.2mg/mL
Anti-HDAC10 Antibody Picoband® (iFluor647 Conjugate)
Cystatin A (CPTC-CSTA-1), CF594 conjugate, 0.1mg/mL
